Advertisement

Infectious Disease

  • Lawrence C. Tsen
  • Errol R. Norwitz
Chapter

Summary

A number of infections are associated with significant maternal and fetal consequences. In general, perinatal infections have more serious fetal consequences when they occur early in gestation, because they may disrupt organogenesis. By contrast, second and third trimester infections are more likely to cause neurologic impairment or growth disturbances. With few exceptions, treatment of infectious diseases is not altered substantially by pregnancy; however, as infectious diseases often dramatically affect the outcome of the pregnancy, obstetric and anesthetic management decisions should be directed with awareness of these pathogens to optimize the outcome for mother and infant.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Obstet Gynecol Lyme Disease Bacterial Vaginosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Liljestrand J. Reducing perinatal and maternal mortality in the world. Br J Obstet Gynaecol 1999;106:877–880.PubMedGoogle Scholar
  2. 2.
    NCCDPHP, CDC. State-specific maternal mortality among black and white women: United States, 1987–1996. MMWR 1999;48:492–496.Google Scholar
  3. 3.
    Sachs B, Brown D, Driscoll S, et al. Maternal mortality in Massachusetts: trends and prevention. N Engl J Med 1987;316:667–672.PubMedCrossRefGoogle Scholar
  4. 4.
    Hogberg U, Innala E, Sabdsrom A. Maternal mortality in Sweden. Obstet Gynecol 1994;84:240–244.PubMedGoogle Scholar
  5. 5.
    American College of Obstetricians and Gynecologists. Antimicrobial therapy for obstetric patients. Educational Bulletin No. 245. Washington, DC: ACOG, 1998.Google Scholar
  6. 6.
    Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338:1128–1137.CrossRefPubMedGoogle Scholar
  7. 7.
    Tsen LC, Tarshis J, Denson DD, et al. Measurements of maternal protein binding of bupivacaine throughout pregnancy. Anesth Analg 1999; 89(4):965–968.CrossRefPubMedGoogle Scholar
  8. 8.
    Sullivan NM, Sutter VL, Mims MM, et al. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis 1973;127(1): 49–55.PubMedGoogle Scholar
  9. 9.
    Morgan PJ. Maternal death following epidural anaesthesia for cesarean section delivery in a patient with unsuspected sepsis. Can J Anaesth 1995;42(4):330–334.PubMedGoogle Scholar
  10. 10.
    Blanco JD, Gibbs RS, Castaneda YS. Bacteremia in obstetrics: clinical course. Obstet Gynecol 1981;58(5):621–625.PubMedGoogle Scholar
  11. 11.
    Wedel DJ, Horlocker TT. Risks of regional anesthesia—infectious, septic. Reg Anesth 1996;21(suppl 6):57–61.PubMedGoogle Scholar
  12. 12.
    Carp H, Bailey S. The association between meningitis and dural puncture in bacteremic rats. Anesthesiology 1992;76(5):739–742.PubMedGoogle Scholar
  13. 13.
    Tsen LC, Pitner R, Camann WR. General anesthesia at a tertiary care hospital 1990–1995: indications and implications. Int J Obstet Anesth 1988;7:147–152.CrossRefGoogle Scholar
  14. 14.
    Hawkins JL, Koonin LM, Palmer SK, Gibbs CP. Anesthesia-related deaths during obstetric delivery in the United States, 1979–1990. Anesthesiology 1997;86(2):277–284.CrossRefPubMedGoogle Scholar
  15. 15.
    American College of Obstetrics and Gynecologists. Group B streptococcal infections in pregnancy. Technical Bulletin No. 170. Washington, DC: ACOG, 1992.Google Scholar
  16. 16.
    American College of Obstetrics and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. Committee Opinion No. 173. Washington, DC: ACOG, 1996.Google Scholar
  17. 17.
    Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90:775–778.Google Scholar
  18. 18.
    Siegal JD, Cushion NB. Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth. Obstet Gynecol 1996;87:692–698.CrossRefGoogle Scholar
  19. 19.
    Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartum use of ampicillin. Am J Obstet Gynecol 1998; 179:879–883.CrossRefPubMedGoogle Scholar
  20. 20.
    Dunn AB, Blomquist J, Khouzami V. Anaphylaxis in labor secondary to prophylaxis against group B streptococcus. J Reprod Med 1999;44: 381–384.PubMedGoogle Scholar
  21. 21.
    Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811–815.CrossRefPubMedGoogle Scholar
  22. 22.
    Davis L, Hargreaves C, Robinson PN. Postpartum meningitis. Anaesthesia 1993;48(9):788–789.PubMedGoogle Scholar
  23. 23.
    Chopin N, Bonnet A, Gabet J. Streptococcus B meningitis after peridural obstetric anesthesia. Ann Fr Anesth Reanim 1998;17(2):195–196.CrossRefPubMedGoogle Scholar
  24. 24.
    Kilpatrick ME, Girgis NI. Meningitis—a complication of spinal anesthesia. Anesth Analg 1983;26(5):513–515.Google Scholar
  25. 25.
    Bader AM, Gilbertson L, Kirz L, Datta S. Regional anesthesia in women with chorioamnionitis. Reg Anesth 1992;17(2):84–86.PubMedGoogle Scholar
  26. 26.
    Goodman EJ, DeHorta E, Taguiam JM. Safety of spinal and epidural anesthesia in parturients with chorioamnionitis. Reg Anesth 1996;21(5): 436–441.PubMedGoogle Scholar
  27. 27.
    Ramanathan J, Vaddadi A, Mercer BM, et al. Epidural anesthesia in women with chorioamnionitis. Anesthesiol Rev 1992;19:35–40.Google Scholar
  28. 28.
    Stagno S, Tinker MK, Elrod C, et al. Immunoglobulin M antibodies detected by enzyme-linked immunosorbant assay and radioimmunoassay in the diagnosis of cytomegalovirus infection in pregnant women and newborn infants. J Clin Microbiol 1985;21:930–935.PubMedGoogle Scholar
  29. 29.
    Fowler KB, Stagno P, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980–1990. J Infect Dis 1993;168:552–556.PubMedGoogle Scholar
  30. 30.
    Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904–1908.CrossRefPubMedGoogle Scholar
  31. 31.
    Fowler KB, Stagno P, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663–667.PubMedCrossRefGoogle Scholar
  32. 32.
    Stagno S, Pass RF, Dworsky ME, Alford CA Jr. Maternal cytomegalo-virus infection and perinatal transmission. Clin Obstet Gynecol 1982;25: 563–576.PubMedGoogle Scholar
  33. 33.
    Drose JA, Dennis MA, Thickman D. Infection in utero: ultrasound findings in 19 cases. Radiology 1991;78:369–374.Google Scholar
  34. 34.
    Stagno S. Cytomegalovirus. In: Remington JS, Klein JO (eds). Infectious Disease of the Fetus and Newborn Infant, 4th ed. Philadelphia: Saunders, 1995:312–353.Google Scholar
  35. 35.
    Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis 1996;15:240–246.CrossRefGoogle Scholar
  36. 36.
    American College of Obstetricians and Gynecologists. Perinatal viral and parasitic infections. Practice Bulletin No. 20. Washington, DC: ACOG, 2000.Google Scholar
  37. 37.
    Attard-Montalto SP, English MC, Strimmler L, Snodgrass GJ. Canciclovir treatment of congenital cytomegalovirus infection: a report of two cases. Scand J Infect Dis 1993;25:385–388.PubMedGoogle Scholar
  38. 38.
    American College of Obstetricians and Gynecologists. Viral hepatitis in pregnancy. Educational Bulletin No. 248. Washington, DC: ACOG, 1998.Google Scholar
  39. 39.
    Wejstal R, Manson AS, Widell A, Norkrans G. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections—a comparison. Clin Infect Dis 1999;28(4):816–821.PubMedGoogle Scholar
  40. 40.
    Bendinelli M, Pistello M, Maggi F, et al. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Microbiol Rev 2001;14(1):98–113.CrossRefGoogle Scholar
  41. 41.
    Rizzetto M. Hepatitis D: virology, clinical and epidemiological aspects. Acta Gastroenterol Belg 2000;63(2):221–224.PubMedGoogle Scholar
  42. 42.
  43. 43.
    Sato T, Hashiguchi A, Mitsuse T. Anesthesia for cesarean delivery in a pregnant woman with acute hepatic failure. Anesth Analg 2000;91(6): 1441–1442.CrossRefPubMedGoogle Scholar
  44. 44.
    Armenti VT, Herrine SK, Radomski JS, Moritz MJ. Pregnancy after liver transplantation. Liver Transplant 2000;6(6):671–685.CrossRefGoogle Scholar
  45. 45.
    Eger EI. New inhaled anesthetics: Sevoflurane and Desflurane. IARS 1997 Review Course Lectures. Cleveland, OH. International Anesthesia Research Society, 1997.Google Scholar
  46. 46.
    Shingu K, Eger EI II, Johnson BH, et al. Effect of oxygen concentration, hyperthermia, and choice of vendor on anesthetic-induced hepatic injury in rats. Anesth Analg 1983;62(2):146–150.PubMedGoogle Scholar
  47. 47.
    Centers for Disease Control & Prevention. Basic Statistics: International Projections. Update Dec 1998. Atlanta, GA: CDC, 1998.Google Scholar
  48. 48.
    Bardequez AD. Management of HIV infection for the childbearing age woman. Clin Obstet Gynecol 1996;39:344–360.CrossRefGoogle Scholar
  49. 49.
    Minkoff H, Henderson C, Mendez H, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990;162;30–34.PubMedGoogle Scholar
  50. 50.
    Minkoff H, Henderson C, Menez R, Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex. Obstet Gynecol 1987;69:285–291.PubMedGoogle Scholar
  51. 51.
    Gloeb DJ, Lai S, Efantis J, O’Sullivan MJ. Survival and disease progression in human immunodeficiency virus-infected women after an index delivery. Am J Obstet Gynecol 1992;167:152–157.PubMedGoogle Scholar
  52. 52.
    Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J 1987;294:143–144.CrossRefGoogle Scholar
  53. 53.
    Kain ZN, Rimar S, Barash PG. Cocaine abuse in the parturient and effects on the fetus and neonate. Anesth Analg 1993;77:835–844.PubMedGoogle Scholar
  54. 54.
    Glantz JC, Roberts DJ. Pregnancy complicated by thrombocytopenia secondary to human immunodeficiency virus infection. Obstet Gynecol 1994;83:825–827.PubMedGoogle Scholar
  55. 55.
    Gwinn M, Wortley PM. Epidemiology of HIV infection in women and newborns. Clin Obstet Gynecol 1996;39:292–304.CrossRefPubMedGoogle Scholar
  56. 56.
    Langston C, Lewis DE, Hammill HA, et al. Excess intrauterine fetal demise associated with maternal immunodeficiency virus infection. J Infect Dis 1995;172:1451–1460.PubMedGoogle Scholar
  57. 57.
    Rogers MF, Shaffer N. Reducing the risk of maternal-infant transmission of HIV by attacking the virus. N Engl J Med 1999;341:441–443.CrossRefPubMedGoogle Scholar
  58. 58.
    Wade NA, Birkhead BS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409–1414.CrossRefPubMedGoogle Scholar
  59. 59.
    Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173–1180.CrossRefPubMedGoogle Scholar
  60. 60.
    The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med 1999;340:977–987.CrossRefGoogle Scholar
  61. 61.
    Sempri AE, Castagna C, Ravizza M, et al. The incidence of complications after cesarean section in 156 HIV-positive women. AIDS 1995;9: 913–917.CrossRefGoogle Scholar
  62. 62.
    Glantz JC, Roberts DJ. Pregnancy complicated by thrombocytopenia secondary to human immunodeficiency virus infection. Obstet Gynecol 1994;83:825–827.PubMedGoogle Scholar
  63. 63.
    Riley LE, Greene MF. Elective cesarean delivery to reduce the transmission of HIV. N Engl J Med 1999;340:1032–1033.CrossRefPubMedGoogle Scholar
  64. 64.
    Hughes SC, Dailey PA, Landers D, et al. Parturients infected with human immunodeficiency virus and regional anesthesia. Anesthesiology 1995;82:32–37.CrossRefPubMedGoogle Scholar
  65. 65.
    Frame WA, Lichtman MW. Blood patch in the HIV-positive patient [letter]. Anesthesiology 1990;73:1297.PubMedGoogle Scholar
  66. 66.
    Bevacqua BK, Slucky AV. Epidural blood patch in a patient with HIV infection [letter]. Anesthesiology 1991;74:952–953.PubMedGoogle Scholar
  67. 67.
    Gibbons JJ. Post dural puncture headache in the HIV positive patient [letter]. Anesthesiology 1991;74:953.PubMedGoogle Scholar
  68. 68.
    Tom DJ, Gulevich SJ, Shapiro HM, et al. Epidural blood patch in the HIV-positive patient. Review of clinical experience. Anesthesiology 1992;76:943–947.PubMedGoogle Scholar
  69. 69.
    Fassoulaki A, Desmonts JM. Prolonged neuromuscular blockade after a single bolus dose of vecuronium in patients with acquired immunodeficiency syndrome. Anesthesiology 1994;80:457–459.PubMedGoogle Scholar
  70. 70.
    Lauretti GR. Infectious diseases. In: Gambling DR, Douglas MJ (eds). Obstetric Anesthesia and Uncommon Disorders. Philadelphia: Saunders, 1998:336.Google Scholar
  71. 71.
    Layon AJ, Peck AB. Anesthetic effects on immune function: where do we stand? In: Stoelting RK, Barash PG, Gallagher TJ (eds). Advances in Anesthesia, vol 10. St. Louis: Mosby, 1993:69–93.Google Scholar
  72. 72.
    Barzan L, Carbone A, Saracchini S, et al. Nasopharyngeal lymphatic tissue hypertrophy in HIV infected patients. Lancet 1989;1:42–43.CrossRefPubMedGoogle Scholar
  73. 73.
    American College of Obstetricians and Gynecologists. Management of herpes in pregnancy. Practice Bulletin No. 8. Washington, DC: ACOG, 1999.Google Scholar
  74. 74.
    Jacobs RF. Neonatal herpes simplex virus infections. Semin Perinatol 1998;22(1):64–71.PubMedGoogle Scholar
  75. 75.
    Woods GL. Update on laboratory diagnosis of sexually transmitted diseases. Clin Lab Med 1995;15(3):665–684.PubMedGoogle Scholar
  76. 76.
    Frenkel LM, Brown ZA, Bryson YJ, et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991;164(2):569–576.PubMedGoogle Scholar
  77. 77.
  78. 78.
    Brown ZA. Genital herpes complicating pregnancy. Dermatol Clin 1998;16(4):805–810.CrossRefPubMedGoogle Scholar
  79. 79.
    Becker TM, Blount JH, Guinan ME. Genital herpes infections in private practice in the United States, 1966 to 1981. JAMA 1985;253(11): 1601–1603.CrossRefPubMedGoogle Scholar
  80. 80.
    Crone LA, Conly JM, Clark KM, et al. Recurrent herpes simplex virus labialis and the use of epidural morphine in obstetric patients. Anesth Analg 1988;67(4):318–323.PubMedGoogle Scholar
  81. 81.
    Boyle RK. A review of anatomical and immunological links between epidural morphine and herpes simplex labialis in obstetric patients. Anaesth Intensive Care 1995;23(4):425–432.PubMedGoogle Scholar
  82. 82.
    Manian FA. Potential role of famciclovir for prevention of herpetic whitlow in the health care setting. Clin Infect Dis 2000;31(4):E18–E19.CrossRefPubMedGoogle Scholar
  83. 83.
    Gellin BG, Broome CV. Listeriosis. JAMA 1989;261:1313–1320.CrossRefPubMedGoogle Scholar
  84. 84.
    Linnan MJ, Mascola L, Lou XD, et al. Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med 1988;319:823–828.PubMedCrossRefGoogle Scholar
  85. 85.
    Steele PE, Jacobs DS. Listeria monocytogenes macroabscesses of placenta. Obstet Gynecol 1979;53:124–127.PubMedGoogle Scholar
  86. 86.
    Boucher M, Yonekura ML. Perinatal listeriosis (early-onset): correlation of antenatal manifestations and neonatal outcome. Obstet Gynecol 1986;68:593–597.PubMedGoogle Scholar
  87. 87.
    Lyme disease—United States, 1999. MMWR (Morb Mortal Wkly Rep) 2001;50(10):181–185.Google Scholar
  88. 88.
    Strobino B, Abid S, Gewitz M. Maternal Lyme disease and congenital heart disease: a case-control study in an endemic area. Am J Obstet Gynecol 1999;180(3 Pt 1):711–716.CrossRefPubMedGoogle Scholar
  89. 89.
    Silver HM. Lyme disease during pregnancy. Infect Dis Clin N Am 1997;11(1):93–97.CrossRefGoogle Scholar
  90. 90.
  91. 91.
    Cadavid D, O’Neill T, Schaefer H, Pachner AR. Localization of Borrelia burgdorferi in the nervous system and other organs in a non-human primate model of Lyme disease. Lab Invest 2000;80(7):1043–1054.PubMedGoogle Scholar
  92. 92.
    Rosenfeld ME, Beckerman B, Ward MF, Sama A. Lyme carditis: complete AV dissociation with episodic asystole presenting as syncope in the emergency department. J Emerg Med 1999;17(4):661–664.CrossRefPubMedGoogle Scholar
  93. 93.
    Saba S, Vander Brink BA, Perides G, et al. Cardiac conduction abnormalities in a mouse model of lyme borreliosis. J Intervent Cardiol Electrophysiol 2001;5(2):137–143.CrossRefGoogle Scholar
  94. 94.
    American College of Obstetricians and Gynecologists. Perinatal viral and parasitic infections. Practice Bulletin. No. 20. Washington, DC: ACOG, 2000.Google Scholar
  95. 95.
    Thurn J. Human parvovirus B19: historical and clinical review. Rev Infect Dis 1988;10:1005–1011.PubMedGoogle Scholar
  96. 96.
    Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999;281(12):1099–1105.CrossRefPubMedGoogle Scholar
  97. 97.
    Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ 1990;3000(6733):1166–1170.Google Scholar
  98. 98.
    Risks associated with human parvovirus B19 infection. MMWR (Morb Mortal Wkly Rep) 1989;38:81–88.Google Scholar
  99. 99.
    Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105(2):174–178.PubMedGoogle Scholar
  100. 100.
    Dieck D, Schild RL, Hansmann M, Eis-Hubinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 1999;19(12): 1119–1123.CrossRefPubMedGoogle Scholar
  101. 101.
    Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: a review. Obstet Gynecol Surv 1997;52(4):254–259.CrossRefPubMedGoogle Scholar
  102. 102.
    Eisele CJ. Rubella susceptibility in women of childbearing age. J Obstet Gynecol Neonatal Nurs 1993;22:260–263.PubMedGoogle Scholar
  103. 103.
    American College of Obstetricians and Gynecologists. Rubella and pregnancy. Technical Bulletin No. 171. Washington, DC: ACOG, 1992.Google Scholar
  104. 104.
    Bosma TJ, Corbett KM, Eckstein MB, et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995;33: 2881–2887.PubMedGoogle Scholar
  105. 105.
    Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781–784.CrossRefPubMedGoogle Scholar
  106. 106.
    Centers for Disease Control. Rubella vaccination during pregnancy—United States, 1971–1988. MMWR 1989;38:289–293.Google Scholar
  107. 107.
    Division of STD Prevention. Sexually transmitted disease surveillance, 1996. U.S. Department of Health and Human Services, Public Health Services. Atlanta, GA: Centers for Disease Control and Prevention, 1997.Google Scholar
  108. 108.
    Centers for Disease Control. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998;47:28–49.Google Scholar
  109. 109.
    Hook EW, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326:1060–1069.PubMedCrossRefGoogle Scholar
  110. 110.
    Ray JG. Lues-Lues: maternal and fetal considerations of syphilis. Obstet Gynecol Surg 1995;50:845–849.CrossRefGoogle Scholar
  111. 111.
    Wendel GD. Gestational and congenital syphilis. Clin Perinatol 1988; 15:287–303.PubMedGoogle Scholar
  112. 112.
    Hook EW, Marra CM. Acquired syphilis in adults. N Engl J Med 1992; 326:1060–1069.PubMedCrossRefGoogle Scholar
  113. 113.
    Wendel GD Jr, Stark BJ, Jamison RB, et al. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985; 312:1229–1232.PubMedCrossRefGoogle Scholar
  114. 114.
    Ziaya PR, Hankins GDV, Gilstrap LC, Halsey AB. Intravenous desensitization and treatment during pregnancy. JAMA 1986;256:2561.CrossRefPubMedGoogle Scholar
  115. 115.
  116. 116.
    Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol 1999;180(2 Pt 1):410–415.CrossRefPubMedGoogle Scholar
  117. 117.
    Perinatal viral and parasitic infections. ACOG Practice Bulletin Number 20. Washington, DC: ACOG, 2001.Google Scholar
  118. 118.
    Stray-Pedersen B. Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol 1993;7:107–137.PubMedGoogle Scholar
  119. 119.
    Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318(5):271–275.PubMedCrossRefGoogle Scholar
  120. 120.
    Mombro M, Perathoner C, Leone A, et al. Congenital toxoplasmosis: 10-year follow-up. Eur J Pediatr 1995;154(8):635–639.PubMedGoogle Scholar
  121. 121.
    Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis Suppl 1992;84:23–31.PubMedGoogle Scholar
  122. 122.
    Patel DV, Holfels EM, Vogel NP, et al. Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology 1996;199(2):433–440.PubMedGoogle Scholar
  123. 123.
    Frieden TR, Sterling T, Pabllo-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521–526.CrossRefPubMedGoogle Scholar
  124. 124.
    Robinson CA, Rose NC. Tuberculosis: current implications and management in obstetrics. Obstet Gynecol Surv 1996;51:115–124.CrossRefPubMedGoogle Scholar
  125. 125.
    Bate TW, Sinclair RE, Robinson MJ. Neonatal tuberculosis. Arch Dis Child 1986;61:512–514.PubMedCrossRefGoogle Scholar
  126. 126.
    Nemir RL, O’Hare D. Congenital tuberculosis. Review and diagnostic guidelines. Am J Dis Child 1985;139:284–287.PubMedGoogle Scholar
  127. 127.
    Kendig EL Jr. The place of BCG vaccine in the management of infants born of tuberculous mothers. N Engl J Med 1969;281:520–523.PubMedCrossRefGoogle Scholar
  128. 128.
    Wang YL, Hong CL, Chung HS, et al. Massive hemoptysis after the initiation of positive pressure ventilation in a patient with pulmonary tuberculosis. Anesthesiology 2000;92(5):1480–1482.CrossRefPubMedGoogle Scholar
  129. 129.
    Pollard BA, El-Beheiry H. Pott’s disease with unstable cervical spine, retropharyngeal cold abscess and progressive airway obstruction. Can J Anaesth 1999;46(8):772–775.PubMedCrossRefGoogle Scholar
  130. 130.
    Varicella-related deaths among adults—United States, 1997. MMWR (Morb Mortal Wkly Rep) 1997;46:409–412.Google Scholar
  131. 131.
    Enders G. Serodiagnosis of varicella-zoster virus infection in pregnancy and standardization of the ELISA IgG and IgM antibody tests. Dev Biol Stand 1982;52:221–236.PubMedGoogle Scholar
  132. 132.
    Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR (Morb Mortal Wkly Rep) 1996;45:1–36.Google Scholar
  133. 133.
    Smego RA Jr, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Ôbstet Gynecol 1991;78:1112–1116.PubMedGoogle Scholar
  134. 134.
    Lecuru F, Taurelle R, Bernard JP, et al. Varicella zoster virus infection during pregnancy: the limits of prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol 1994;56:67–68.CrossRefPubMedGoogle Scholar
  135. 135.
    Isada NB, Paar DP, Johnson MP, et al. In utero diagnosis of congenital varicella zoster virus infection by chorionic villus sampling and polymerase chain reaction. Am J Obstet Gynecol 1991;165:1727–1730.PubMedGoogle Scholar
  136. 136.
    Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548–1551.CrossRefPubMedGoogle Scholar
  137. 137.
    Pastuszak AL, Levy M, Schick B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330:901–905.CrossRefPubMedGoogle Scholar
  138. 138.
    Brunell PA. Fetal and neonatal varicella-zoster infections. Semin Perinatol 1983;7:47–56.PubMedGoogle Scholar
  139. 139.
    Wallace MR, Bowler WA, Murray NB, et al. Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med 1998;36:31–38.Google Scholar
  140. 140.
    The American Academy of Pediatrics Committee on Infectious Disease: the use of oral acyclovir in otherwise healthy children with varicella. Pediatrics 1993;91:858.Google Scholar
  141. 141.
    Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome in newborn babies given antivaricella-zoster immunoglobulin after perinatal infection with varicella-zoster virus. Lancet 1989;8659:371–373.CrossRefGoogle Scholar
  142. 142.
    Varicella-zoster immune globulin for the prevention of chickenpox. Recommendations of the Immunization Practices Advisory Committee, Centers for Disease Control. Ann Intern Med 1984;100:859–865.Google Scholar
  143. 143.
    Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000;87(2):121–129.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2004

Authors and Affiliations

  • Lawrence C. Tsen
  • Errol R. Norwitz

There are no affiliations available

Personalised recommendations